Literature DB >> 26472666

Promotion of Latina Health: Intersectionality of IPV and Risk for HIV/AIDS.

Michele A Rountree1, Teresa Granillo2, Meredith Bagwell-Gray3.   

Abstract

Latina women in the United States are vulnerable to two intersecting public health concerns: intimate partner violence (IPV) and subsequent risk for HIV/AIDS infection. Examination of the cultural and contextual life factors of this understudied population is crucial to developing culturally relevant HIV interventions. Focus groups with Latinas (15 monolingual; 10 bilingual) who have experienced IPV were conducted. Monolingual and bilingual Latinas endorsed that they were concerned about HIV infection, naming partner infidelity and experiences of forced and coerced sex as primary reasons for their concern. However, monolingual participants had lower levels of HIV knowledge, spending much time discussing myths of HIV infection, whereas bilingual participants spent more time discussing specific prevention techniques, including challenges related to the violence in their relationships. These findings suggest that HIV/AIDS prevention programs for Latinas need to pay close attention to the different historical, contextual, and cultural experiences of this at-risk group of women.
© The Author(s) 2015.

Entities:  

Keywords:  HIV/AIDS prevention; HIV/AIDS risk-reduction interventions; Latinas; intimate partner violence

Mesh:

Year:  2015        PMID: 26472666     DOI: 10.1177/1077801215607358

Source DB:  PubMed          Journal:  Violence Against Women        ISSN: 1077-8012


  2 in total

1.  Structural and syndemic barriers to PrEP adoption among Black women at high risk for HIV: a qualitative exploration.

Authors:  Liesl A Nydegger; Julia Dickson-Gomez; Thant Ko Ko
Journal:  Cult Health Sex       Date:  2020-03-26

2.  Exploring patterns of substance use among highly vulnerable Black women at-risk for HIV through a syndemics framework: A qualitative study.

Authors:  Liesl A Nydegger; Kasey R Claborn
Journal:  PLoS One       Date:  2020-07-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.